+Compare
ATRI
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
544.19M

ATRI Atrion Corp Forecast, Technical & Fundamental Analysis

a manufacturer of medical products and components for the medical and health care industry

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for ATRI with price predictions
07:00 PM EST Dec 03, 2023

Momentum Indicator for ATRI turns positive, indicating new upward trend

ATRI saw its Momentum Indicator move above the 0 level on November 30, 2023. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 104 similar instances where the indicator turned positive. In of the 104 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ATRI's RSI Oscillator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ATRI just turned positive on November 20, 2023. Looking at past instances where ATRI's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ATRI advanced for three days, in of 280 cases, the price rose further within the following month. The odds of a continued upward trend are .

ATRI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATRI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ATRI entered a downward trend on November 27, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.266) is normal, around the industry mean (25.181). P/E Ratio (25.620) is within average values for comparable stocks, (79.553). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.249). Dividend Yield (0.028) settles around the average of (0.019) among similar stocks. P/S Ratio (3.236) is also within normal values, averaging (44.232).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ATRI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATRI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.4B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 4%. For the same Industry, the average monthly price growth was 10%, and the average quarterly price growth was -10%. LNDZF experienced the highest price growth at 347%, while GENE experienced the biggest fall at -81%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -42%. For the same stocks of the Industry, the average monthly volume growth was -62% and the average quarterly volume growth was -43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 60
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: 19 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I.Advisor
published Dividends

ATRI is expected to pay dividends on December 15, 2023

Atrion Corp ATRI Stock Dividends
A dividend of $2.20 per share will be paid with a record date of December 15, 2023, and an ex-dividend date of November 30, 2023. The last dividend of $2.20 was paid on September 29. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of medical products and components for the medical and health care industry

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Allentown Parkway
Phone
+1 972 390-9800
Employees
722
Web
https://www.atrioncorp.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TGCEX29.02N/A
N/A
TCW Select Equities I
AEURX8.71N/A
N/A
American Century Equity Income R
TGJNX21.10N/A
N/A
TCW Artificial Intelligence Equity N
FBKFX13.74N/A
N/A
Fidelity® Balanced K6
FULVX10.63N/A
N/A
Fidelity® US Low Volatility Equity

ATRI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRI has been loosely correlated with ATRC. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRI jumps, then ATRC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRI
1D Price
Change %
ATRI100%
+0.77%
ATRC - ATRI
35%
Loosely correlated
-0.25%
AHCO - ATRI
34%
Loosely correlated
+4.19%
ALC - ATRI
32%
Poorly correlated
-3.43%
RVTY - ATRI
31%
Poorly correlated
+0.57%
IQV - ATRI
28%
Poorly correlated
-0.26%
More

Groups containing ATRI

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRI
1D Price
Change %
ATRI100%
+0.77%
healthcare
(undefined stocks)
68%
Closely correlated
+1.56%
medical devices
(undefined stocks)
41%
Loosely correlated
+0.34%
medical research
(undefined stocks)
37%
Loosely correlated
+1.16%
medical service
(undefined stocks)
36%
Loosely correlated
+1.24%
Medical Specialties
(undefined stocks)
33%
Loosely correlated
+0.47%
More